Pharmaceuticals News and Research

RSS

Controlling diarrhoea and constipation in autistic children without using antibiotics

Scientists checking bacteria which live in the intestines of autistic children may have found a way to control gut problems, such as diarrhoea or constipation, without using antibiotics

8 Sep 2004

FDA approval for chewable ADHD tablets

Alliant Pharmaceuticals has announced FDA approval of Methylin Chewable Tablets and Methylin Oral Solution for the treatment of ADHD. The two products are the first, and only, chewable tablet and oral solution for ADHD to gain FDA acceptance.

7 Sep 2004

People should be aware of the risks of herbal remedies interacting with conventional medicines

A high percentage of the population could be endangering their health by taking herbal medicines without checking with a health professional first according to Peter Houghton, Professor in Pharmacognosy, King’s College London.

7 Sep 2004

Increasingly the Internet's potential is being harnessed to transform healthcare delivery at the patient level

To date, the Internet has been used principally as a tool for commerce and as a cost-effective communication medium by the European healthcare industry. Increasingly however, the Internet's potential is being harnessed to transform healthcare delivery at the patient level.

6 Sep 2004

Air conditioning coil reduces over all sickness by 20%

Air conditioning coil reduces over all sickness by 20%, reduces respiratory symptoms by 40% and has resulted in a 99% reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation system.

5 Sep 2004

Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR

Pfizer has filed lawsuits against a second group of operators of eighteen internet sites for selling unapproved and illegal copies of Pfizer’s leading cholesterol medicine, LIPITOR®, the company said today.

2 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

University of Nottingham research developments could mean new drugs will reach cancer patients more quickly

A £3 million grant and the establishment of a specialized business unit that will help new treatments reach cancer patients more quickly, have underlined The University of Nottingham’s place at the forefront of cancer drug development.

2 Sep 2004

New drug application for exenatide has been accepted for review

Amylin Pharmaceuticals and Eli Lilly today announced that the New Drug Application for exenatide has been accepted for review by the Food and Drug Administration.

2 Sep 2004

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA today announced that they have signed a definitive merger agreement under which MGI PHARMA will acquire all outstanding equity of Aesgen for $32 million in cash.

1 Sep 2004

Danish medical tycoon buys buying worldwide rights to 25 herbal medical products

Danish medical tycoon, Erik Sprunk-Jansen, former CEO of pharmaceutical company Lundbeck, now implements an ambitious venture to create a global company for herbal medicine.

1 Sep 2004

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

The Australian Government response to Senate inquiry into hepatitis C and blood supply

Although the Inquiry found that decision makers had made reasonable decisions in the 80s, based on the evidence available, medically acquired hepatitis C has hurt many people.

30 Aug 2004

Vast majority of heart attacks may be predicted by nine easily measurable factors

A major Canadian-led global study has found that the vast majority of heart attacks may be predicted by nine easily measurable factors and that these factors are the same in virtually every region and ethnic group worldwide.

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Artificial heart can keep patients awaiting heart transplant alive

The results of the nine-year study of the CardioWest Total Artificial Heart have concluded that the device prevents death in critically ill patients suffering from irreversible failure of both sides of the heart who are candidates for heart transplantation.

26 Aug 2004

Powdered form of anthrax vaccine could eliminate needle injections

Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.

26 Aug 2004

Pharmaceuticals News and Research

Controlling diarrhoea and constipation in autistic children without using antibiotics

FDA approval for chewable ADHD tablets

People should be aware of the risks of herbal remedies interacting with conventional medicines

Increasingly the Internet's potential is being harnessed to transform healthcare delivery at the patient level

Air conditioning coil reduces over all sickness by 20%

Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR

World needs to commit more resources to treat people infected with HIV

University of Nottingham research developments could mean new drugs will reach cancer patients more quickly

New drug application for exenatide has been accepted for review

MGI PHARMA acquires Aesgen for $32 million

Danish medical tycoon buys buying worldwide rights to 25 herbal medical products

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Kiwis reverse heart disease in diabetics

The Australian Government response to Senate inquiry into hepatitis C and blood supply

Vast majority of heart attacks may be predicted by nine easily measurable factors

U.S. FDA study shows Canadian drugs to be more expensive

Cymbalta, treatment for major depression hits the market

FDA reinforces use of Sustiva in first-line HIV combination therapy

Artificial heart can keep patients awaiting heart transplant alive

Powdered form of anthrax vaccine could eliminate needle injections

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News